MBX Biosciences, Inc. (MBX) stock
MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$55.94+1.43 (+2.62%)
Close on Nov 13, 2026Market cap $2.69BP/E –Yield –
MBX Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MBX Biosciences's enterprise value was $2.35B on Nov 11, 2026, against $1.15B a year earlier. Over the last 2 years it ranged from -$51.89M to $2.70B, with a median of $512.79M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.35B | +130.6% |
| 2025 | Dec 31, 2025 | $1.02B | +201.4% |
| 2024 | Dec 31, 2024 | $338.02M | – |
See a number that looks wrong?